These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 14990053)
1. [Cyclin D2 expression in chronic myelogenous leukemia]. Song JM; Xu D; Fan EJ; Xu SR; Li D; Zhao CH Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):103-5. PubMed ID: 14990053 [TBL] [Abstract][Full Text] [Related]
2. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts. Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826 [TBL] [Abstract][Full Text] [Related]
3. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells]. Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468 [TBL] [Abstract][Full Text] [Related]
4. [Effects of anti-ABL tyrosine kinase intrabody on the growth of K562 cells in nude mice]. Xu D; Song JM; Hu Y; Guo H; Cao DJ; Wang P; Liu H; Zhao CH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):11-4. PubMed ID: 12905832 [TBL] [Abstract][Full Text] [Related]
5. [Study on mismatch repair genes of chronic myeloid leukemia]. Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):103-6. PubMed ID: 16732964 [TBL] [Abstract][Full Text] [Related]
6. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859 [TBL] [Abstract][Full Text] [Related]
7. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients. Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759 [TBL] [Abstract][Full Text] [Related]
8. [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine]. Sun JR; Zhang XH; He ZW; Gu Y; Yu YZ; Fang YM; Lü QH; Dong QH; Xu RZ Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2246-51. PubMed ID: 17064567 [TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172 [TBL] [Abstract][Full Text] [Related]
11. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456 [TBL] [Abstract][Full Text] [Related]
12. [Detection of phosphotyrosine in bcr-abl-positive cells with PY20 antibody and its clinical applications]. Zhu HH; Liu YR; Qin YZ; Chang Y; Li JL; Ruan GR; Jiang B; Chen SS; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):441-4. PubMed ID: 17147244 [TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair. Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976 [TBL] [Abstract][Full Text] [Related]
14. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells. Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636 [TBL] [Abstract][Full Text] [Related]
15. Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells. Jena N; Deng M; Sicinska E; Sicinski P; Daley GQ Cancer Res; 2002 Jan; 62(2):535-41. PubMed ID: 11809706 [TBL] [Abstract][Full Text] [Related]
16. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation. Gery S; Tanosaki S; Hofmann WK; Koppel A; Koeffler HP Oncogene; 2005 Feb; 24(9):1589-97. PubMed ID: 15674331 [TBL] [Abstract][Full Text] [Related]
17. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia. Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827 [TBL] [Abstract][Full Text] [Related]
18. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells. Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector. Sengupta A; Banerjee D; Chandra S; Banerjee S J Gene Med; 2006 Oct; 8(10):1251-61. PubMed ID: 16952195 [TBL] [Abstract][Full Text] [Related]
20. Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562. Yin DD; Fan FY; Hu XB; Hou LH; Zhang XP; Liu L; Liang YM; Han H Leuk Res; 2009 Jan; 33(1):109-14. PubMed ID: 18687467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]